Science Explorer Back to mapMap
Institution · Ogeda (Belgium)

Most cited papers from Ogeda (Belgium)

What are the most cited papers from Ogeda (Belgium)?

The most cited paper from Ogeda (Belgium) is "Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial" (Herman T. Depypere, Dirk Timmerman, Gilbert G.G. Donders et al., 2019), with 153 citations. Next come "A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia" (97) and "Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome" (56).

Showing 12 of 12 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial Herman T. Depypere, Dirk Timmerman, Gilbert G.G. Donders et al. · The Journal of Clinical Endocrinology & Metabolism Open access 15 Aug 2019 153
2 A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia Thomas Suply et al. · Science Signaling 12 Sep 2017 97
3 Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome Graeme L. Fraser, Barbara Maria Obermayer-Pietsch, Joop S.E. Laven et al. · The Journal of Clinical Endocrinology & Metabolism Open access 17 May 2021 56
4 Assessment of a Urinary Kidney MicroRNA Panel as Potential Nephron Segment-Specific Biomarkers of Subacute Renal Toxicity in Preclinical Rat Models Stéphanie Glineur, Étienne Hanon, Sarah Dremier et al. · Toxicological Sciences Open access 28 Aug 2018 15
5 Clinical evaluation of the NK3 receptor antagonist fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes Herman T. Depypere, Dirk Timmerman, Gilbert G.G. Donders et al. · Maturitas Aug 2017 13
6 Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury Jana Obajdin, Mabel Cotter, Sara Snelling et al. · Toxicological Sciences 22 Aug 2018 12
7 Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis Ingrid Dubois-Vedrenne, Olivier De Henau, Virginie Robert et al. · Frontiers in Oncology Open access 15 Nov 2019 11
8 OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study Graeme L. Fraser, Samuel N. Lederman, Arthur S. Waldbaum et al. · Journal of the Endocrine Society Open access Apr 2019 3
9 N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model Hamid R. Hoveyda, Graeme L. Fraser, Ludivine Zoute et al. · Bioorganic & Medicinal Chemistry Open access 17 Sep 2018 3
10 Clinical Pharmacokinetics, Mass Balance and Metabolism of Fezolinetant in Postmenopausal Women Megumi Iwai, Kinya Souda, Mayuko Miyagawa et al. · European Journal of Drug Metabolism and Pharmacokinetics Open access 9 Apr 2026 0
11 Concentration–QTc Modeling to Support Clinical Development of Fezolinetant Jace C. Nielsen, Masako Saitō, Xuegong Wang et al. · Clinical Pharmacology in Drug Development Open access 19 Oct 2025 0
12 In Vitro Characterization of Agonist Binding and Functional Activity at a Panel of Serotonin Receptor Subtypes for Lasmiditan, Triptans and Other 5-HT Receptor Ligands and Activity Relationships for Contraction of Human Isolated Coronary Artery (S32.003) Antoinette MaassenVanDenBrink, Alejandro Labastida‐Ramírez, Antoon van den Bogaerdt et al. · Neurology 10 Apr 2018 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.